LKSOM Researchers Show Synthetic Compound Derived from Flaxseed Can Improve Heart Function in Septic Mice

In a new study published online in the Journal of Molecular and Cellular Cardiology, scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) became the first to show that a novel synthetic compound derived from flaxseed, a whole grain celebrated for its potent antioxidant properties, can reverse deterioration of the heart muscle and improve heart function in mice with sepsis. Konstantinos Drosatos, PhD, is the senior investigator on the study and Assistant Professor of Pharmacology and Assistant Professor in the Center for Translational Medicine and the Center for Metabolic Disease Research at LKSOM. Coverage was provided by PhillyVoice, Scienmag, Medical Xpress, and News-Medical, in addition to other outlets.